U.S. Building Stock News

NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

Is SPS Commerce (SPSC) Now Attractive After A 55% One Year Share Price Slump

If you are wondering whether SPS Commerce shares are now priced attractively or still look expensive, you are not alone. This review is aimed squarely at that question. The stock most recently closed at US$58.41, with returns of 7.7% over the past week, a 34.6% decline over 30 days, a 33.6% decline year to date, and a 55.8% decline over 1 year. The 3 year and 5 year returns stand at 61.2% and 41.1% declines respectively. Recent coverage around SPS Commerce has focused on keeping investors...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Veracyte (VCYT) Valuation Check After Mixed Short And Long Term Share Price Performance

Veracyte (VCYT) has drawn attention after recent share price moves, with the stock showing mixed returns across different time frames, including declines over the past month and past 3 months alongside a positive 1 year total return. See our latest analysis for Veracyte. At a share price of US$36.01, Veracyte’s recent performance reflects fading short term momentum, with a 30 day share price return of 5.44% and a 90 day share price return of a 21.99% decline, set against a 1 year total...
NYSE:VIRT
NYSE:VIRTCapital Markets

Why Virtu Financial (VIRT) Is Up 6.9% After Blockbuster Q4 and New Crypto Ambitions

In late February 2026, Virtu Financial reported Q4 2025 results showing its highest quarterly adjusted net income since early 2021, supported by elevated market volatility and strong trading volumes across both Market Making and Execution Services. An interesting angle for investors is Virtu’s plan to channel this momentum into higher trading capital, upgraded infrastructure, and moves into emerging areas such as prediction markets and crypto. We’ll now explore how this stronger quarter,...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

The Bull Case For Zenas BioPharma (ZBIO) Could Change Following Obexelimab’s Commercial Pivot And Cash War Chest

Zenas BioPharma has recently been highlighted for moving from a pre-revenue stage toward commercialization of its lead antibody therapy obexelimab, targeting IgG4-Related Disease, an area with no approved treatments. An interesting aspect of this story is Zenas’ reported cash position of about US$270,000,000 entering 2026, which supports its plans to expand a pipeline focused on B‑cell‑mediated autoimmune diseases while advancing obexelimab toward market. Against this backdrop, we’ll examine...
NYSE:FLR
NYSE:FLRConstruction

Is Fluor (FLR) Pricing Reflect Recent 38% Rally And Mixed Valuation Signals

If you are looking at Fluor and wondering whether the current share price gives you good value, you are not alone. This article focuses squarely on what you might be paying for compared to what you are getting. After closing at US$50.91, the stock has seen a 1.4% decline over the last 7 days, a 10.2% gain over 30 days, a 22.1% return year to date, and a 37.9% return over the past year, which may change how investors think about both upside and risk. Recent attention on Fluor has been driven...
NYSE:XZO
NYSE:XZOInsurance

Exzeo Group Flood Partnership Tests Valuation Concerns And Growth Hopes

Exzeo Group has entered into a new partnership with Tokio Marine Highland to distribute TMH2O residential flood insurance. The collaboration expands Exzeo’s property insurance offerings and supports its ambitions as a multi-line, technology driven platform. For investors tracking NYSE:XZO, this announcement comes as the stock trades at $16.1, with a 3.7% gain over the past week and a 20.8% decline over the past month. Year to date, shares show a 29.3% decline, so this move may stand out as...
NYSE:CRL
NYSE:CRLLife Sciences

Assessing Charles River Laboratories (CRL) Valuation After Recent Mixed Share Price Performance

Event overview and recent share performance Charles River Laboratories International (CRL) has drawn investor attention after recent share price moves, with the stock flat over the past day, up about 9% over the past week, but showing a 15% decline over the past month. Over the past 3 months, Charles River has posted a small positive total return, while year to date the stock is down about 12%. Over the past year, it has delivered roughly 9% total return, set against weaker 3 year and 5 year...
NYSE:VG
NYSE:VGOil and Gas

US Stock Market Today S&P 500 Futures Fall On Rising Yield And Inflation Worries

The Morning Bull - US Market Morning Update Tuesday, Mar, 3 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 1.5%, the Nasdaq 100 futures off nearly 2% and small cap Russell 2000 futures lower by about 2.6%. The pressure comes as the US 10 year Treasury yield holds near 4.04%, which keeps borrowing costs elevated for households and businesses, and as global government bond yields in the UK and Europe climb on renewed inflation worries tied to...
NYSE:ALK
NYSE:ALKAirlines

Is Alaska Air Group (ALK) Pricing Reflect Recent Airline Sector Risks Accurately

If you are wondering whether Alaska Air Group is attractively priced at its current level, looking closely at how its valuation stacks up against its fundamentals can help frame that decision. The stock last closed at US$50.77, with returns of 0.3% over the past 7 days, a 0.1% decline over 30 days, a 1.5% decline year to date, a 27.4% decline over 1 year, a 6.0% gain over 3 years and a 25.3% decline over 5 years, which gives you a mixed picture of recent and longer term performance. Recent...
NYSE:AZO
NYSE:AZOSpecialty Retail

Is AutoZone (AZO) Still Attractively Priced After A Strong Multi‑Year Share Price Run?

If you are wondering whether AutoZone's share price still reflects good value after a long run in the auto parts sector, this article will help you break that question into clear valuation checks. AutoZone shares most recently closed at US$3,882.47, with returns of 1.4% over 7 days, 4.8% over 30 days, 17.5% year to date, 11.6% over 1 year, 54.1% over 3 years and 212.8% over 5 years. This gives plenty of history for investors to consider. Recent news coverage around AutoZone has focused on...
NasdaqGS:ARHS
NasdaqGS:ARHSSpecialty Retail

Arhaus (ARHS) Valuation Check After Recent Share Price Pullback

Why Arhaus Stock Is Drawing Attention Now Arhaus (ARHS) has pulled back recently, with the share price down over the past month and past 3 months. This move is prompting investors to reassess how its current valuation lines up with the underlying business. The company reports annual revenue of US$1,379.2m and net income of US$67.3m, and some models suggest the shares trade at a sizeable discount to certain intrinsic value estimates. This can attract interest from value oriented investors. See...
NYSE:SPG
NYSE:SPGRetail REITs

A Look At Simon Property Group (SPG) Valuation As Shares Trade Near Analyst Targets

Simon Property Group (SPG) has drawn fresh attention after its recent share performance, with the stock closing at $203.16 and posting gains over the past week, month, past 3 months and year. See our latest analysis for Simon Property Group. While the share price slipped 0.34% on the day to US$203.16, the 30 day share price return of 6.19% and year to date gain of 10.43% suggest momentum has been building, supported by a 1 year total shareholder return of 13.68% and very strong 3 and 5 year...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise Targets AI Growth With Juniper Integration Push

Hewlett Packard Enterprise (NYSE:HPE) has introduced new AI native networking and compute solutions ahead of Mobile World Congress 2026. The launch includes expanded integration of Juniper Networks technology across HPE's networking portfolio. HPE is pairing these AI focused offerings with new financing options aimed at service providers scaling AI infrastructure and modern networks. Hewlett Packard Enterprise, trading at $22.13, is putting fresh attention on AI centric networking and...
NasdaqCM:USAU
NasdaqCM:USAUMetals and Mining

Is U.S. Gold (USAU) Using Its Conference Spotlight To Recast Management Credibility With Investors?

U.S. Gold Corp. recently presented at the Emerging Growth Virtual Conference on February 25, 2026, with Executive Chairman Luke Anthony Norman addressing investors. This appearance gave the company a platform to highlight its latest corporate developments and project plans directly to a broad investment audience. We’ll now explore how U.S. Gold Corp.’s Emerging Growth Virtual Conference presentation could shape its investment narrative and investor expectations. The best AI stocks today may...
NYSE:PHM
NYSE:PHMConsumer Durables

How Investors Are Reacting To PulteGroup (PHM) Launching Its $300 Million Hilliard Isle Community

PulteGroup recently presented at the 47th Annual Raymond James Institutional Investor Conference and, through Pulte Homes, has broken ground on Hilliard Isle, a US$300 million, 900-acre master-planned community in Kissimmee featuring more than 2,000 homes and extensive resort-style amenities. These developments come as PulteGroup contends with slowing orders, margin pressure, and a declining backlog, while still outperforming recent earnings expectations through what management describes as...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

A Look At LKQ (LKQ) Valuation As Activist-Driven Business Review Raises Sale Prospects

LKQ (LKQ) has initiated a formal review of its business after renewed pressure from activist investors, putting potential asset sales or even a full company sale on the table for shareholders. See our latest analysis for LKQ. LKQ's formal review comes after a tough run for long term holders, with a 1 year total shareholder return decline of 19.3% and a 3 year total shareholder return decline of 38.1%. At the same time, the 90 day share price return of 12.3% suggests momentum has recently...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

Could WD-40 (WDFC) Strengthen Governance Without Shifting Its Core Capital Allocation Priorities?

WD-40 Company recently expanded its board of directors to 10 members by appointing Ken Plunk, a former J&J Snack Foods chief financial officer and long-time Wal-Mart executive, to serve on its Audit and Finance Committees effective February 18, 2026. This appointment brings extensive financial, international operations, and risk oversight experience to WD-40’s board, potentially strengthening governance around capital allocation, global expansion, and operational efficiency. Next, we’ll...
NYSE:GKOS
NYSE:GKOSMedical Equipment

Glaukos’ 2025 Loss, Impairment and ESOP Shelf Might Change The Case For Investing In GKOS

In February 2026, Glaukos Corporation reported past fourth-quarter and full-year 2025 results showing sales rising to US$143.12 million for the quarter and US$507.44 million for the year, alongside a larger net loss and a US$112,867,000 impairment of intangible assets, and it also issued 2026 net sales guidance of US$600 million to US$620 million. Glaukos has also filed a US$69.25 million shelf registration tied to an ESOP-related common stock offering, highlighting how the company is...
NYSE:CHD
NYSE:CHDHousehold Products

Assessing Church & Dwight (CHD) Valuation After Recent Share Price Momentum And Mixed Return Profile

Why Church & Dwight is on investors’ radar today Church & Dwight (CHD) is drawing fresh attention after a period in which the share price and fundamentals have moved in different directions, prompting investors to reassess how the business is currently priced. The stock has returned about 8% over the past month and roughly 24% in the past 3 months, while the 1 year total return is a 6% decline. That split between recent momentum and longer term performance often leads investors to look more...
NasdaqGS:CCEC
NasdaqGS:CCECShipping

Should Capital Clean Energy Carriers’ €250 Million Bond and 2025 Results Timing Require Action From CCEC Investors?

Capital Clean Energy Carriers Corp. recently priced a €250 million unsecured bond issue in Greece, maturing in 2033 with a 3.75% semi-annual coupon, and has also announced that its fourth-quarter 2025 financial results will be released on March 5, 2026. The bond proceeds earmarked for debt repayment, capital expenditure and working capital shed light on how CCEC is reshaping its balance sheet and funding future growth projects. We’ll explore how this €250 million unsecured bond issuance may...
NYSE:DTM
NYSE:DTMOil and Gas

What DT Midstream (DTM)'s Strong 2025 Results and Bigger Project Pipeline Mean For Shareholders

DT Midstream, Inc. reported full-year 2025 results showing sales rising to US$1,243 million and net income to US$441 million, alongside a 7% dividend increase to US$0.88 per share and a US$396.99 million shelf registration for 3,000,000 shares related to its ESOP. Management’s disclosure that its project pipeline is several times larger than the announced US$3.40 billion capital plan, with growth expected to outpace a 7% annualized rate through the rest of the decade, points to a materially...
NYSE:PSN
NYSE:PSNProfessional Services

Assessing Parsons (PSN) Valuation After Bastion Asset Management’s New Fourth Quarter Stake

Institutional Buying Puts Parsons in Focus Bastion Asset Management’s new fourth quarter position in Parsons (PSN), totaling 128,186 shares worth about US$8.04 million, has put fresh attention on the contractor’s government and infrastructure exposure. See our latest analysis for Parsons. Parsons’ share price closed at US$67.86 after a 2.82% 1 day share price return. Despite an 18.12% 90 day share price decline, the 1 year total shareholder return of 22.60% and 5 year total shareholder return...
NasdaqCM:VRDN
NasdaqCM:VRDNBiotechs

Viridian Therapeutics (VRDN) Valuation After Wider Q4 Loss And Ongoing Thyroid Eye Disease Regulatory Reviews

Viridian Therapeutics (VRDN) is in focus after reporting a larger than expected Q4 2025 loss and lower than forecast revenue. Its lead thyroid eye disease candidate remains under FDA Priority Review and EMA review. See our latest analysis for Viridian Therapeutics. At a share price of US$30.25, Viridian’s 1 day share price return of 2.96% and 7 day share price return of 7.77% follow a weaker 30 day share price return of an 8.33% decline. The 1 year total shareholder return of 109.92%...
NYSE:RVTY
NYSE:RVTYLife Sciences

Reassessing Revvity (RVTY) Valuation After Prolonged Share Price Weakness

Revvity (RVTY) has recently drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months and year. See our latest analysis for Revvity. With the share price at $95.59 and a 30 day share price return of 12.14% decline, recent weakness builds on a softer trend, as the 1 year total shareholder return of 13.16% decline and 3 year total shareholder return of 25.03% decline point to fading momentum despite...